Biotech

All Articles

Arch shuts $3B-plus fund to encourage biopharma upstarts

.On the heels of a $3 billion fund from Bain Funding Lifestyle Sciences, Arch Venture Allies is show...

Orion to use Aitia's 'digital doubles' to locate new cancer medicines

.Finnish biotech Orion has spied possible in Aitia's "digital identical twin" specialist to establis...

Windtree's shock med raises high blood pressure in most current period 2 succeed

.While Windtree Therapies has actually struggled to expand the financial roots needed to survive, a ...

2 cancer biotechs combine, making global footprint

.OncoC4 is actually taking AcroImmune-- as well as its own internal professional production function...

Amgen files 1st phase 3 gain for $400M chronic eczema drug

.Amgen has discussed (PDF) the initial phase 3 records on its $400 thousand chronic eczema medicine,...

Biogen, UCB document period 3 lupus gain after stopping working earlier test

.Biogen and UCB's bank on improving in to stage 3 astride a broken research study hopes to have paid...

Aptadir hopes brand new RNA preventions can turn around difficult cancers cells

.Italian biotech Aptadir Therapeutics has released along with the guarantee that its own pipeline of...

Wave surfs DMD success to regulatory authorities' doors, sending out stock up

.Wave Life Sciences has actually met its objective in a Duchenne muscle dystrophy (DMD) study, posit...

Sanofi tweezes brand new CSO from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is actually going back to the pharma fold, takin...

Achilles splashes tissue treatment system, prepares for layoffs after skipping 'commercial feasibility' objectives

.Achilles Therapeutics has actually torn up its own strategy. The British biotech is actually stoppi...